Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. - sprookjes - yvandenbroek - TriplyDB

Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

http://www.wikidata.org/entity/Q33693164

about

In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.Vibrio vulnificus in Taiwan Vibrio Vulnificus Necrotizing Fasciitis Associated with Acupuncture.Vibrio vulnificus Septicemia After Handling Tilapia Species Fish: A Canadian Case Report and Review.In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.

P2860

Q33825683-5DACD288-7D36-4C77-9092-70D5C243A961 Q33938029-FCCDD4E4-7BD9-4F3D-AAD1-41105C4D0F5F Q33981986-89D0F2B2-0426-45D3-807C-AE2AE6243E11 Q34142225-FA688B36-A48B-478F-9D73-E8F4044357E9 Q35873202-559DF51A-87A8-472F-9168-F4AD211EEF2A Q36123045-AA5EA48E-8CCD-4564-BB3D-658B51A1C01C Q36171152-80C0E115-A8A3-4448-A67F-2D77B421CE17 Q36744813-C2B23BA6-B7A6-45E9-95C1-D66D123E2580 Q41991766-68EA88FB-9D04-4413-B5E9-A8B3D57354C0

P2860

Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

http://www.wikidata.org/entity/Q33693164

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Minocycline and cefotaxime in ...... e Vibrio vulnificus infection.

@ast

Minocycline and cefotaxime in ...... e Vibrio vulnificus infection.

@en

type

label

Minocycline and cefotaxime in ...... e Vibrio vulnificus infection.

@ast

Minocycline and cefotaxime in ...... e Vibrio vulnificus infection.

@en

prefLabel

Minocycline and cefotaxime in ...... e Vibrio vulnificus infection.

@ast

Minocycline and cefotaxime in ...... e Vibrio vulnificus infection.

@en

P1433

Q33693164-43BD3C38-08BA-4837-B0C9-662C1736F28E

P1476

Q33693164-21BCD778-6758-48D8-B3E0-15AB09674D14

P2093

Q33693164-42A7DB1D-3BC5-4C4B-A43F-97B1DFBE539B

Q33693164-5A00900A-0CCC-4A5B-AE01-BEAE441E58E6

Q33693164-74296785-58F3-4B23-9B24-71FFDEA58DAF

Q33693164-8EDDFE64-0287-4B50-9CE5-BB3518A26238

Q33693164-A6B7AD07-6CF6-4CE1-AC48-52A7DCBF141C

Q33693164-AD86A166-69C1-4732-96DD-B55CF61EBE9C

Q33693164-D17E90D1-E4EB-48AB-B6A8-3B9C969BEBBA

P2860

Q33693164-079A9B77-532D-4F52-906C-09785C5D92CF

Q33693164-1E4CA121-30DA-445F-8147-80B8AA953544

Q33693164-29DCE08A-FC95-4F4B-B77B-3CD136734BA0

Q33693164-3C2365C8-DD62-44B0-9768-2BE53846D1AE

Q33693164-3CEB11B7-C174-4E99-BBC5-3C26D63858BD

Q33693164-53B5C3B3-8DD6-46DB-9482-EA63AF31BB3A

Q33693164-5B2F00E1-92E6-4097-8B1A-C8413C843F1A

Q33693164-BF857E3B-8269-436C-8D42-E037F0BCD14F

Q33693164-CC0116E1-7268-40A7-A2C5-CE333B80CE27

Q33693164-CD17FAB3-2C29-4179-8175-0B0CD173CA57

P304

Q33693164-A1E57109-7316-41E7-914C-4A98A8EA08FC

P31

Q33693164-8292FCAC-4CB7-4027-9CB5-530482CEA3AD

P356

Q33693164-DEBBFD4B-8DEA-4FC2-9E90-CC39CBCB9D45

P407

Q33693164-F284139A-838F-4C17-9E3B-9BEB438AADE4

P433

Q33693164-4C5D49B2-319D-4862-83FD-C369B0333E9F

P478

Q33693164-1DDA7A56-A7A1-4DEE-A5E4-32070B36A85D

P577

Q33693164-F7232B5E-CE35-4505-B37B-16CA490D3E12

P698

Q33693164-34C0CA4E-0584-46FD-BFDF-685A6236FEC7

P932

Q33693164-54BD33C0-FDBD-40C3-B921-921B4992BA81

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Minocycline and cefotaxime in ...... ne Vibrio vulnificus infection

@en

P2093

C F Kuo

http://www.w3.org/2001/XMLSchema#string

J J Wu

http://www.w3.org/2001/XMLSchema#string

J W Liu

http://www.w3.org/2001/XMLSchema#string

K Y Huang

http://www.w3.org/2001/XMLSchema#string

S T Wang

http://www.w3.org/2001/XMLSchema#string

W C Ko

http://www.w3.org/2001/XMLSchema#string

Y C Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp.

In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.

Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment.

Cholera and other vibrioses in the United States.

Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim.

Disease caused by a marine Vibrio. Clinical characteristics and epidemiology.

In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan.

Use of tetracycline for treatment of Vibrio vulnificus infections.

Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline.

Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients.

P304

1319-1322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.42.6.1319

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9624467

http://www.w3.org/2001/XMLSchema#string

P932

105595

http://www.w3.org/2001/XMLSchema#string